整体素和肺纤维化:致病作用和治疗机会
Zhangyang Bi1, Guodong Zang2, Xiaodong Wang2
1Clinical Department of Integrated Traditional Chinese and Western Medicine, The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
Biomolecules & biomedicine
|June 19, 2025
概括
肺纤维化 (PF) 涉及复杂的病原和有限的治疗方法. 这项研究详细介绍了整合素对PF的贡献,并审查了当前基于整合素的疗法,提供了新的诊断和治疗视角.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 医学科学 医学科学 医学科学
背景情况:
- 肺纤维化 (PF) 是一种严重的肺病,死亡率高,治疗选择有限.
- 集成蛋白是细胞信号传递和细胞外基质重塑至关重要的跨膜蛋白,在PF病原发生过程中起着关键作用.
- 由于PF的复杂性和整合因的多样性,目前的整合因向治疗面临挑战.
研究的目的:
- 系统地划分与PF相关的集成信号网络.
- 通过免疫调节途径揭示整合素对PF贡献的分子机制.
- 审查基于整合素的疗法的发展,并确定研究重点.
主要方法:
- 集成信号网络的系统划分.
- 在PF病原体中的分子机制的分析.
- 对基于整合素的疗法进行的临床前和临床研究的审查.
主要成果:
- 鉴定出有助于PF的特定整合素信号通路.
- 发现了整合素在PF免疫病原发生过程中的作用.
- 总结了整体向疗法的进展和挑战.
结论:
- 集成蛋白是PF发展和进展中的关键调节剂.
- 了解整合素信号传递为PF提供了新的治疗策略.
- 需要在临床,基础和翻译科学方面进行进一步的研究,以获得有效的基于整合素的治疗方法.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
282
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
282
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
Cystic Fibrosis: Pathogenesis
358
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
358
COPD: Pathogenesis and Clinical Features
512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223


